Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections

World J Hepatol. 2016 Nov 8;8(31):1295-1308. doi: 10.4254/wjh.v8.i31.1295.


Alcohol use disorder (AUD) and hepatitis C virus (HCV) infection frequently co-occur. AUD is associated with greater exposure to HCV infection, increased HCV infection persistence, and more extensive liver damage due to interactions between AUD and HCV on immune responses, cytotoxicity, and oxidative stress. Although AUD and HCV infection are associated with increased morbidity and mortality, HCV antiviral therapy is less commonly prescribed in individuals with both conditions. AUD is also common in human immunodeficiency virus (HIV) infection, which negatively impacts proper HIV care and adherence to antiretroviral therapy, and liver disease. In addition, AUD and HCV infection are also frequent within a proportion of patients with HIV infection, which negatively impacts liver disease. This review summarizes the current knowledge regarding pathological interactions of AUD with hepatitis C infection, HIV infection, and HCV/HIV co-infection, as well as relating to AUD treatment interventions in these individuals.

Keywords: Alcohol; Hepatitis C virus; Hepatitis C virus/human immunodeficiency virus co-infection; Human immunodeficiency virus; Liver.

Publication types

  • Review